This site is using Google Analytics to increase its usability. If you take issue with the collection of your data, you can either visit  this page to install an addon that prevents the use of Google Analytics on all pages or simply click this link to prevent the collection of your data on this site only.

ICRC-Weyer To Monitor Advanced Therapy Trials

ICRC-Weyer GmbH has recently extended its clinical monitoring services portfolio to monitoring for trials in the area of stem cell research. The enhanced portfolio enables the German all-phase CRO to serve the demands of the global pharmaceutical industry in the growing field of regenerative medicine. On May 10, 2012, a group of representatives from ICRC-Weyer GmbH attended a colloquium on regulatory requirements for the development of cell-based medicine which took place at Beuth University in Berlin, Germany (Clinical Trial Management Colloquium).

This site is using Google Analytics to increase its usability. If you take issue with the collection of your data, you can either visit  this page to install an addon that prevents the use of Google Analytics on all pages or simply click this link to prevent the collection of your data on this site only.